A significant shift in our drug policy has occurred, as the government allow the use of psilocybin fungi for therapeutic treatment. Previously, these substances were heavily restricted, but a increasing body of evidence suggests they could offer benefits for emotional illnesses like anxiety. This development represents a key step toward rethinking